mTOR Signaling Pathway and Its Relationship with Atherosclerosis
Author:
Affiliation:

1.Beijing University of Chinese Medicine, ;2.Oriental Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100029, China)

Clc Number:

R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [28]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    mTOR is a serine/threonine kinase, mainly involved in two kinds of signal pathway in regulation. mTOR signaling pathway can regulate cell growth, proliferation and apoptosis. While the mTOR can regulate the process of atherosclerosic development about endothelial cells migration and proliferation, macrophage autophagy, smooth muscle cells proliferation and migration. By inhibiting or activating mTOR in different periods, the vulnerable plaque of atherosclerosis can be stabilized and the development of atherosclerosis can be prevented. mTOR signaling pathway plays a multifaceted effect in atherosclerosis progression. This paper mainly review the relationship of mTOR signaling pathway and atherosclerosis. It provides a new direction for the clinical treatment.

    Reference
    [1] Bai X, Jiang Y.Key factors in mTOR regulation.Cell Mol Life Sci, 0,7 (2):239-253.
    [2] Bhaskar PT, Hay N.The two TORCs and Akt.Dev Cell, 7,2:487-502.
    [3] Martin DE, Hall MN.The expanding signaling network.Curr Opin Cell Biol, 5,7:158-166.
    [4] 张慧敏, 韩雅玲, 陶杰, 等.雷帕霉素对内皮细胞迁移和血管内皮生长因子表达的影响.现代生物医学进展, 1,2:4 209-211.
    [5] 刘海涛.雷帕霉素抑制内皮细胞增殖和迁移:PI3K/Akt/mTOR/p70S6K信号通路的作用.第四军医大学, 2010.
    [6] Suzuki K, Tanaka S, Yanagi K, et al.Epalrestat induces cell proliferation and migration in endothelial cells via mTOR activation through PI3/Akt signaling.Diabetology International, 4,5(2):105-111.
    [7] Lin S, Shao NN, Fan L, et al.Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR.Huazhong Univ Sci Technolog Med Sci, 4,4 (6):889-895.
    [8] 彭楠.靶向mTORC1的新型丁内酯衍生物3BDO抑制ox-LDL诱导的内皮细胞自噬和ApoE―/―小鼠的动脉粥样硬化.山东大学, 2014.
    [9] 陈正军, 黄翔.PI3K信号通路及其抑制剂抗恶性肿瘤的研究进展.实用医院临床杂志, 1,8 (3):140-143.
    [10] 朱政, 孙守刚, 许广莉, 等.大鼠颈动脉球囊损伤后平滑肌细胞mTOR-P70S6K表达.中国老年学杂志, 0,5:2 171-173.
    [11] 张萌, 吴峻, 王玮, 等.AMPK经过mTOR途径对大鼠血管平滑肌细胞增殖的影响.山东大学学报(医学版), 0,8 (6):17-21.
    [12] 陈孔,曾高峰, 唐朝克.巨噬细胞增殖和凋亡与动脉粥样硬化.中国动脉硬化杂志, 4,2 (9):965-969.
    [13] Liao X, Sluimer JC, Wang Y, et al.Macrophage autophagy plays a protective role in advanced atherosclerosis.Cell Metab, 2,5 (4):545-553.
    [14] 许秋莲, 杨阳, 田野.巨噬细胞自噬在动脉粥样硬化中的作用.中国动脉硬化杂志, 6,4 (1):97-100.
    [15] Duewell P, Kono H, Rayner KJ, et al.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.Nature, 0,4 (7293):1 357-361.
    [16] 郭凤霞, 危当恒.自噬与动脉粥样硬化.生命的化学, 3,3 (4):461-465.
    [17] Velikkakath AK, Nishinura T, Oita E, et al.Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets.Mol Biol Cell, 2,3 (5):896-909.
    [18] 王和峰, 翟纯刚, 庞文会, 等.PI3K/Akt/mTOR信号通路在巨噬细胞自噬及动脉粥样硬化斑块不稳定中的作用.中国病理生理杂志, 3,9 (3):390-397.
    [19] Martinet W, De Loof H, De Meyer GRY.mTOR inhibition:a promising strategy for stabilization of atherosclerotic plaques.Atherosclerosis, 4,3 (2):601-607.
    [20] Martinet W, De Meyer I, Verheye S, et al.Drug-induced macrophage autophagy in atherosclerosis:for better or worse.Basic Res Cardiol, 3,8 (1):321.
    [21] 李进, 邹祥.雷帕霉素及其衍生物开发现状、作用机制及生物合成研究进展.中国抗生素杂志, 1,6 (11):806-813.
    [22] Guertin DA, Sabatini DM.The pharmacology of mTOR inhibition.Sci Signal, 9,2 (67):20-24.
    [23] Zhang YJ, Duan Y, Zheng XF.Targeting the mTOR kinase domain:the second generation of mTOR inhibitors.Drug Discov Today, 1,6 (7-8):325-331.
    [24] Schenone S, Brullo C, Musumeci F, et al.ATP-competitive inhibitors of mTOR:an update.Curr Med Chem, 1,8 (20):2 995-3 014.
    [25] Babcock JT, Quilliam LA.Rheb/mTOR activation and regulation in cancer:novel treatment strategies beyond rapamycin.Curr Drug Targets, 1,2 (8):1 223-231.
    [26] 陈颖, 韩进松, 宋云龙, 等.PI3K-mTOR双重小分子抑制剂的研究进展.药学实践杂志, 4,2(5):332-336.
    [27] 张慧锋, 李妍, 白雪, 等.mTOR信号通路及其抑制剂的研究进展.中国畜牧兽医, 3,0 (2):36-41.
    [28] 黄平, 丁惠萍, 任华益.mTOR抑制剂依维莫司在肿瘤治疗中的临床应用.肿瘤药学, 3,3 (6):422-425.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

HU Mu, ZHANG Yong-Sheng, KONG Bing-Tan, CHAI Xin-Lou. mTOR Signaling Pathway and Its Relationship with Atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(12):1269-1272, 1278.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 23,2015
  • Revised:March 10,2016
  • Online: February 09,2017
Article QR Code